The Board of Directors of MMRGlobal, Inc. approved a 1-for-5 reverse split of its common stock for the purpose of making available authorized common stock to allow the company to explore and possibly enter into transactions involving strategic alliances with health information technology firms, biotechnology firms and pharmaceutical companies, as well as the potential acquisition of pharmaceutical assets and other information technology firms.